Sensei Biotherapeutics, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation DE
Business Address 1405 RESEARCH BLVD, SUITE 125, ROCKVILLE, MD, 20850
Mailing Address 1405 RESEARCH BLVD, SUITE 125, ROCKVILLE, MD, 20850
Phone (240) 243-8000
Fiscal Year End 1231
EIN 000000000
Financial Overview
FY2025
-$21.09M
Net Income
$6.97M
Total Liabilities
$64.89M
Stockholders' Equity
$9.99M
Cash & Equivalents
$-16.72
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 30, 2026 | View on SEC |
| 10-K Annual financial report | March 30, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 25, 2026 | View on SEC |
| 4 Insider stock transaction report | February 19, 2026 | View on SEC |
| 3 Initial insider ownership report | February 19, 2026 | View on SEC |
| 8-K Current report of material events | February 18, 2026 | View on SEC |
| 4 Insider stock transaction report | February 17, 2026 | View on SEC |
| 3 Initial insider ownership report | February 17, 2026 | View on SEC |
| 8-K Current report of material events | February 13, 2026 | View on SEC |
| 8-K Current report of material events | December 23, 2025 | View on SEC |
Annual Reports
10-K March 30, 2026
- Acquired Faeth Therapeutics to pivot focus toward metabolism-based cancer therapies.
- Lead drug candidate PIKTOR (FT-101) targets solid tumors with Phase 2 results expected in late 2026.
Material Events
8-K Acquisition March 30, 2026
High Impact
- Strategic acquisition of Faeth Therapeutics pivots company to metabolic-oncology.
- PIKTOR (FT-101) established as the new lead clinical-stage asset.
Insider Trading
STRONG SELL 2 insiders
16 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.